Journal article · 2026

Discovery of 7-Aminofuro[2,3- c ]pyridine-Based Irreversible Inhibitors of TGFβ-Activated Kinase 1 (TAK1) with In Vivo Antitumor Activity

Yingying Zuo, Tiancheng Fu, Xuan Chen, Fengli He, Xingwei Chen, Lars Wortmann, Volker Schulze, Tobias Kerst Heinrich, Detlev Suelzle, Franz von Nussbaum, Zhengying Pan

Journal of Medicinal Chemistry, 69(21), 25434–25447 · Published 31 October 2026 · DOI 10.1021/acs.jmedchem.6c01364

View at the publisherCite this paper

In brief

“Discovery of 7-Aminofuro[2,3- c ]pyridine-Based Irreversible Inhibitors of TGFβ-Activated Kinase 1 (TAK1) with In Vivo Antitumor Activity” is a 2026 journal article by Yingying Zuo and 10 co-authors, published in Journal of Medicinal Chemistry. OpenAlex counts 0 citations as of 17 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
0
References
39
Authors
11

Abstract

TGFβ-activated kinase 1 (TAK1) plays essential roles in proinflammatory and prosurvival signaling pathways, and has been implicated in various human diseases, including cancer and inflammation. Although several TAK1 inhibitors have been reported, an effective tool compound with a combination of favorable potency, selectivity, and in vivo efficacy is still lacking. Herein, we present a 7-aminofuro[2,3-c]pyridine-based… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Zuo, Y., Fu, T., Chen, X., He, F., Chen, X., Wortmann, L., Schulze, V., Heinrich, T. K., Suelzle, D., von Nussbaum, F., & Pan, Z. (2026). Discovery of 7-Aminofuro[2,3- c ]pyridine-Based Irreversible Inhibitors of TGFβ-Activated Kinase 1 (TAK1) with In Vivo Antitumor Activity. Journal of Medicinal Chemistry, 69(21), 25434–25447. https://doi.org/10.1021/acs.jmedchem.6c01364

MLA 9

Zuo, Yingying, et al. “Discovery of 7-Aminofuro[2,3- c ]pyridine-Based Irreversible Inhibitors of TGFβ-Activated Kinase 1 (TAK1) with In Vivo Antitumor Activity.” Journal of Medicinal Chemistry, vol. 69, no. 21, 2026, pp. 25434–25447. https://doi.org/10.1021/acs.jmedchem.6c01364.

Chicago

Zuo, Yingying, Tiancheng Fu, Xuan Chen, Fengli He, Xingwei Chen, Lars Wortmann, Volker Schulze, et al. 2026. “Discovery of 7-Aminofuro[2,3- c ]pyridine-Based Irreversible Inhibitors of TGFβ-Activated Kinase 1 (TAK1) with In Vivo Antitumor Activity.” Journal of Medicinal Chemistry 69 (21): 25434–25447. https://doi.org/10.1021/acs.jmedchem.6c01364.

Harvard

Zuo, Y. et al. (2026) ‘Discovery of 7-Aminofuro[2,3- c ]pyridine-Based Irreversible Inhibitors of TGFβ-Activated Kinase 1 (TAK1) with In Vivo Antitumor Activity’, Journal of Medicinal Chemistry, 69(21), pp. 25434–25447. doi:10.1021/acs.jmedchem.6c01364.

IEEE

Y. Zuo et al., “Discovery of 7-Aminofuro[2,3- c ]pyridine-Based Irreversible Inhibitors of TGFβ-Activated Kinase 1 (TAK1) with In Vivo Antitumor Activity,” Journal of Medicinal Chemistry, vol. 69, no. 21, pp. 25434–25447, 2026, doi: 10.1021/acs.jmedchem.6c01364.

BibTeX

@article{zuo2026discovery,
  title     = {{Discovery of 7-Aminofuro[2,3- c ]pyridine-Based Irreversible Inhibitors of TGFβ-Activated Kinase 1 (TAK1) with In Vivo Antitumor Activity}},
  author    = {Zuo, Yingying and Fu, Tiancheng and Chen, Xuan and He, Fengli and Chen, Xingwei and Wortmann, Lars and Schulze, Volker and Heinrich, Tobias Kerst and Suelzle, Detlev and von Nussbaum, Franz and Pan, Zhengying},
  journal   = {Journal of Medicinal Chemistry},
  year      = {2026},
  volume    = {69},
  number    = {21},
  pages     = {25434--25447},
  doi       = {10.1021/acs.jmedchem.6c01364},
  url       = {https://doi.org/10.1021/acs.jmedchem.6c01364}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Physical Sciences › Chemistry › Organic Chemistry › Heterocyclic Compound Synthesis and Bioactivity

  • TAK1
  • α,β-unsaturated aldehydes
  • anticancer activity
  • lymphoma
  • kinase selectivity

Work with this paper

Most-cited papers in Chemistry

All highly cited Chemistry papers

Questions about this paper

How do I cite this paper in APA style?

Zuo, Y., Fu, T., Chen, X., He, F., Chen, X., Wortmann, L., Schulze, V., Heinrich, T. K., Suelzle, D., von Nussbaum, F., & Pan, Z. (2026). Discovery of 7-Aminofuro[2,3- c ]pyridine-Based Irreversible Inhibitors of TGFβ-Activated Kinase 1 (TAK1) with In Vivo Antitumor Activity. Journal of Medicinal Chemistry, 69(21), 25434–25447. https://doi.org/10.1021/acs.jmedchem.6c01364

How many times has this paper been cited?

0 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Yingying Zuo, Tiancheng Fu, Xuan Chen, Fengli He, Xingwei Chen, Lars Wortmann, Volker Schulze, Tobias Kerst Heinrich, Detlev Suelzle, Franz von Nussbaum, Zhengying Pan.

What is the DOI of this paper?

10.1021/acs.jmedchem.6c01364, permanently at https://doi.org/10.1021/acs.jmedchem.6c01364. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.